Annette Tumolo - 02 Sep 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: Executive Vice President
Signature: /s/ Annette Tumolo
Issuer symbol: BIO
Transactions as of: 02 Sep 2021
Net transactions value: -$123,866
Form type: 4
Filing time: 03 Sep 2021, 17:10:47 UTC
Previous filing: 27 Aug 2021
Next filing: 08 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad A Common Stock	Options Exercise	$0	+433	+14%	$0.000000	3,532	02 Sep 2021	Direct	F1
transaction	BIO	Bio-Rad A Common Stock	Tax liability	$123,866	-150	-4.2%	$825.77	3,382	02 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Options Exercise	$0	-433	-25%	$0.000000	1,300	02 Sep 2021	Bio-Rad A Common Stock	433	$0.000000	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3	On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.